Discover how the incidence of vision loss in Diabetic sufferers is being minimised using a revolutionary, low cost testing device that is quick, accurate and 100% comfortable for the patient
Leading Australian supplier AMA Medical Products reveals how global diagnostics company - Welch Allyn - have released a product that objectively screens diabetic patients for Vision Threatening Diabetic Retinopathy (VTDR) in just three minutes
People with all types of Diabetes (Type 1, Type 2 and Gestational) are at risk of Diabetic Retinopathy. The risk increases the longer the person has diabetes.
What is Diabetic Retinopathy?
Diabetic Retinopathy involves changes to the retinal blood vessels that can cause them to bleed or leak fluid, distorting vision. Chronically high blood sugar from diabetes is associated with damage to the tiny blood vessels in the retina, leading to Diabetic Retinopathy. The retina detects light and converts it to signals sent to the optic nerve to the brain. In its most
advanced stage, new abnormal blood vessels proliferate (increase in number) on the surface of the retina, which can lead to scarring and cell loss in the retinal.
The current standard is a screening test during a consultation with an Opthalmologist (Eye Specialist). The problem is that using eye specialists for all screening has proven ineffective because around 50% of patients do not comply with the annual referrals for diabetic exams.
The early stages of Diabetic Retinopathy usually have no symptoms. Patients suffering with Diabetes don't feel the need for, or recognise the importance of an early screening test.
TRAGICALLY DOCUMENTED COMPLIANCE WITH VISION-SAVING ANNUAL EXAMS IS OFTEN LESS THAN 50%
COMFORTABLE NON-MYDRIATIC SCREENING TAKES JUST 3 MINUTES
WITH EARLY DETECTION, 95% OF VISION LOSS CASES CAN BE PREVENTED
EARLY SCREENING IS VITAL!
Most patients either ignore the call for testing or simply avoid it because they know the Gold Standard for detecting Diabetic Retinopathy is one of high cost and high level discomfort.
Gold Standard Screener vs RETeval DR
GOLD STANDARD SCREENING - MANY ISSUES
THE SOLUTION HAS ARRIVED!
The RETeval DR is an Electroretinograph that measures the electrical responses of the retina to light stimulation. The activity is magnified and recorded as waves, similar to an ECG. Signals from a deceased retina are reduced in size and slower than normal.
FUNCTION TEST (PASS/FAIL)
NON-MYDRIATIC FOR COMFORT & CONVENIENCE
FAST 3 MINUTE CHECK
ANYBODY CAN USE RETeval DR
HOW DOES IT WORK?
1. Introduce 30 Hz flashes of light to the retina
2. Light stimulates cone structures in the retina
3. The cones electrical response to light is destined for the optic nerve, but also radiates through the facial structure
4. We measure the electrical response time and strength using skin electrodes on the cheek
5. As the eye becomes more ischaemic...
- Response time gets longer
- Signal strength gets weaker
- Pupil responds less
6. These 3 parameters (plus age) combine into a RETeval-DR "Score" that correlates to VTDR
WHY PRACTITIONERS ARE CHOOSING RETeval - DR ELECTRORETINOGRAPH
TRUSTED GLOBAL BRAND
HIGH ACCURACY AND LOW TECHNICAL FAILURE RATE
HANDHELD AND BATTERY POWERED
IMMEDIATE TEST RESULTS AND REPORTS
NO INSTALLATION AND MINIMUM TRAINING REQUIRED
UNIQUE ELECTRORETINOGRAPH (ERG) MADE SIMPLE
AMA MEDICAL PRODUCTS